Connect with us

Bloomberg Technology

Moderna’s Chairman on Biden’s COVID-19 Vaccine Promise

Jan.20 — Moderna Co-Founder and Chairman Noubar Afeyan discusses President Biden’s COVID-19 vaccine distribution plan and its chances of success. He also talks about the shortcomings of the initial vaccine rollout. Afeyan speaks to Emily Chang on “Bloomberg Technology.”

Published

on

Jan.20 — Moderna Co-Founder and Chairman Noubar Afeyan discusses President Biden’s COVID-19 vaccine distribution plan and its chances of success. He also talks about the shortcomings of the initial vaccine rollout. Afeyan speaks to Emily Chang on “Bloomberg Technology.”

Continue Reading
Advertisement
27 Comments

27 Comments

  1. Captain Bum face

    January 21, 2021 at 6:55 am

    More communist propaganda

  2. squeeze bag

    January 21, 2021 at 10:37 am

    Propaganda.

  3. Breezy Breezy

    January 21, 2021 at 12:04 pm

    No safety questions?

  4. James Rushe

    January 21, 2021 at 1:13 pm

    REST IN PEACE TIFFANY DOVER.

  5. Mit Hall

    January 21, 2021 at 3:42 pm

    They stopped giving the Moderna vax in California.

  6. Beyond Human

    January 21, 2021 at 5:10 pm

    ????

  7. This comment protected Under the 1st Amendment

    January 21, 2021 at 5:10 pm

    Gosh, I’m sold now. They got the co-founder and chairman on the show! There’s no reason why the people who are making this would be lying…
    The harder they push this, the more I distrust them. As should anyone else that has a working brain.

    • William Infinite

      January 21, 2021 at 5:49 pm

      WHO just announced the PCR test has been run incorrectly. Officially…

    • This comment protected Under the 1st Amendment

      January 21, 2021 at 6:13 pm

      @William Infinite
      Anyone following what’s actually going on knows that Kerry Mullis, the creator of the pcr test, specifically stated that these tests are not diagnostic tests and are not to be used as such.

    • William Infinite

      January 21, 2021 at 6:18 pm

      @This comment protected Under the 1st Amendment I know but the illogical exist…

  8. William Infinite

    January 21, 2021 at 5:52 pm

    The WHO just announced officially that the PCR test has be run incorrectly. This pandemic is bull crap.

  9. NewWorld Abnormal

    January 21, 2021 at 6:03 pm

    If everyone who dies within 28 days of “testing positive” is classed as a “COVID death” then why isn’t everyone who dies within 28 days of the vaxx classed as a “Vaccine death”?

  10. BrNv RoT

    January 21, 2021 at 6:04 pm

    idc

  11. Wanda Mayhew

    January 21, 2021 at 6:07 pm

    The attached are some of the weirdest comments I can imagine. And, I have a great imagination.

  12. Stella Rocquie

    January 21, 2021 at 6:12 pm

    Support Legislation in the U.S. to END COURT ORDERED RAPE!

  13. Peter Piper

    January 21, 2021 at 6:16 pm

    Freedom Doses.

  14. NEW YORK Channel NORTH CAROLINA

    January 21, 2021 at 6:17 pm

    Biden baldy stealing voted ???? deaths voted ????lord’s god’s

  15. A.A. Weaver

    January 21, 2021 at 6:28 pm

    oh… is this still a thing?

  16. Bones Thundergun

    January 21, 2021 at 6:37 pm

    What a bunch of BS! Dems want extreme population control!

  17. John Burns

    January 21, 2021 at 7:55 pm

    Read, W.H.O. Murdered Africa, by Dr William Campbell Douglas. To better understand the Truth about COVID-19 read, “This Is A Bio-Attack Alert”, by Dr Robert B Strecker. Dr Fauci was the NIH AIDS Expert and after 30 Years they are still looking for AIDS Vaccines.

  18. ManapuaMan

    January 22, 2021 at 12:51 am

    Thanks Media! Now I can think for myself!

  19. Greg Laird

    January 22, 2021 at 12:54 am

    He couldn’t walk a hundred steps in his first hundred days of office

  20. Isaac Newton

    January 22, 2021 at 12:55 am

    Trash.

  21. Hawaiisidecar

    January 22, 2021 at 12:58 am

    The vaccine makes young women infertile. Give it to your daughter and you won’t have grandchildren.

  22. Sara

    January 22, 2021 at 12:59 am

    just got my first dose of the Moderna vax on Tuesday. My arm got a little sore (less sore than a tetanus shot) and I feel a tad tired. That’s it. Doing just fine.

  23. Robot

    January 22, 2021 at 1:22 am

    Where is Tiffany Dover?

  24. star shine

    January 22, 2021 at 1:26 am

    Many have been dying within a couple of weeks after receiving first Pfizer vaccine….in other countries and in the US. The US National news is keeping it hush hush….but local news reports on the ones that die in their area….but the people won’t get a full country view from local news.

Leave a Reply

Your email address will not be published. Required fields are marked *

Bloomberg Technology

Anthropic Files for IPO in Global Race to Raise Cash for AI

Anthropic filed for its long-awaited IPO, a landmark moment in an industry that is growing ever-hungrier for cash to power ahead. Ed Ludlow reports. ——– Like this video? Subscribe to Bloomberg Tech on YouTube:   Watch the latest full episodes of “Bloomberg Tech” with Ed Ludlow here:   Get the latest in tech from Silicon…

Published

on

Anthropic filed for its long-awaited IPO, a landmark moment in an industry that is growing ever-hungrier for cash to power ahead. Ed Ludlow reports.
——–
Like this video? Subscribe to Bloomberg Tech on YouTube:

 
Watch the latest full episodes of “Bloomberg Tech” with Ed Ludlow here:

 
Get the latest in tech from Silicon Valley and around the world here:

Connect with us on…
X:
Facebook:
Instagram:
 
Follow Ed Ludlow on X here:
 
Listen to the daily Bloomberg Tech podcast here:

 
More from Bloomberg Business
Connect with us on…
X:
Facebook:
Instagram:
LinkedIn:
TikTok:

Continue Reading

Bloomberg Technology

Anthropic Drops Its S-1, Giving Market Glimpse Into Finances

Bloomberg’s Ed Ludlow takes a look at Anthropic’s regulatory filing as the company prepares to go public under the ticker ANT. The S-1 revealed Anthropic’s revenue and spending, along with its plan for an unusual corporate structure. Plus, venture investors are in line for a big payday when Anthropic goes public. Matt Murphy from Menlo…

Published

on

Bloomberg’s Ed Ludlow takes a look at Anthropic’s regulatory filing as the company prepares to go public under the ticker ANT. The S-1 revealed Anthropic’s revenue and spending, along with its plan for an unusual corporate structure. Plus, venture investors are in line for a big payday when Anthropic goes public. Matt Murphy from Menlo Ventures and Byron Deeter from Bessemer Venture Partners discuss what they think happens next for the AI market.

00:00:00 – Bloomberg Tech Begins
00:00:45 – Shirin Ghaffary & Sridhar Natarajan on Anthropic IPO filing
00:06:03 – Gil Luria, DA Davidson on Anthropic’s cost of compute
00:15:06 – Lori Keith, Parnassus Investments on Anthropic Investments
00:21:01 – Sarah Frier on Meta raising money for AI spending
00:23:31 – Brody Ford on Microsoft offering buyouts to 60,000 workers
00:24:47 – Natasha Mascarenhas on Anthropic funding details
00:27:47 – Rohit Kulkarni, Burnham Park on Anthropic IPO filing
00:34:20 – Byron Deeter, Bessemer Venture Partners on Anthropic
00:41:58 – Rachel Metz, Bloomberg News
00:44:13 – Matt Murphy, Menlo Ventures on Anthropic IPO
——–
“Bloomberg Technology” is our daily news program focused exclusively on technology, innovation and the future of business hosted by Ed Ludlow from San Francisco and Caroline Hyde in New York.

Like this video? Subscribe and turn on the notifications for Bloomberg Technology on YouTube:

Watch the latest full episodes of “Bloomberg Technology” with Caroline Hyde and Ed Ludlow here:

Get the latest in tech from Silicon Valley and around the world here:

Follow Ed Ludlow on Twitter here:
Follow Caroline Hyde on Twitter here:

Connect with us on…
Twitter:
Facebook:
Instagram:

Continue Reading

Bloomberg Technology

Anthropic IPO Is the “One We’ve Been Waiting For”: Bessemer’s Deeter

Anthropic’s IPO will finally give public market investors a chance to get into the software side of AI, says Byron Deeter, partner at Bessemer Venture Partners. Bessemer first invested in Anthropic during its Series D, and Deeter explains the impact Anthropic going public will have on limited partners. He joins Ed Ludlow on “Bloomberg Tech”.…

Published

on

Anthropic’s IPO will finally give public market investors a chance to get into the software side of AI, says Byron Deeter, partner at Bessemer Venture Partners. Bessemer first invested in Anthropic during its Series D, and Deeter explains the impact Anthropic going public will have on limited partners. He joins Ed Ludlow on “Bloomberg Tech”.
——–
Like this video? Subscribe to Bloomberg Tech on YouTube:

 
Watch the latest full episodes of “Bloomberg Tech” with Ed Ludlow here:

 
Get the latest in tech from Silicon Valley and around the world here:

Connect with us on…
X:
Facebook:
Instagram:
 
Follow Ed Ludlow on X here:
 
Listen to the daily Bloomberg Tech podcast here:

 
More from Bloomberg Business
Connect with us on…
X:
Facebook:
Instagram:
LinkedIn:
TikTok:

Continue Reading

Trending